Structure-guided engineering and molecular simulations to design a potent monoclonal antibody to target aP2 antigen for adaptive immune response instigation against type 2 diabetes

Overview of attention for article published in Frontiers in immunology, March 2024

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (63rd percentile)
High Attention Score compared to outputs of the same age and source (80th percentile)

Mentioned by

twitter: 8 X users

Readers on

mendeley: 4 Mendeley

Summary X

So far, Altmetric has seen 8 X posts from 8 X users, with an upper bound of 53,734 followers.

RT @FrontImmunol: New Research: Structure-guided engineering and molecular simulations to design a potent monoclonal antibody to target aP2…

11 Mar 2024

Reply Repost Favourite

RT @FrontImmunol: New Research: Structure-guided engineering and molecular simulations to design a potent monoclonal antibody to target aP2…

10 Mar 2024

Reply Repost Favourite

Interesante. La sustitución T94M, junto con otras mutaciones identificadas, mejora el potencial terapéutico del anticuerpo CA33 contra la Diabetes Mellitus al mejorar su afinidad y estabilidad de unión. https://t.co/n89qeLTu4U

10 Mar 2024

Reply Repost Favourite

RT @FrontImmunol: New Research: Structure-guided engineering and molecular simulations to design a potent monoclonal antibody to target aP2…

10 Mar 2024

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 4 additional X posts.